Drug Group Says Fed. Law Doesn't Bar $600M NY Opioid Levy Suit
By James Nani · November 9, 2018, 6:17 PM EST
New York's $600 million surcharge on pharmaceutical manufacturers and distributors isn't a tax, and therefore a suit against the law is not barred by the federal Tax Injunction Act, a pharmaceutical...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login